Log on / register
Feedback | Support | My details
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Langerød A, Zhao H, Borgan , Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS
Breast Cancer Res 2007, 9:R30
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM
Cancer Res 2008 Jun 15, 68:4674-82
[PubMed Central] [PubMed] [Related articles]

2.
MDM2 Expression and Regulation in Prostate Cancer Racial Disparity.
Wang G, Firoz EF, Rose A, Blochin E, Christos P, Pollens D, Mazumdar M, Gerald W, Oddoux C, Lee P, Osman I
Int J Clin Exp Pathol 2009, 2:353-60
[PubMed Central] [PubMed] [Related articles]

3.
Oncogenomic Approaches in Exploring Gain of Function of Mutant p53.
Donzelli S, Biagioni F, Fausti F, Strano S, Fontemaggi G, Blandino G
Curr Genomics 2008 May, 9:200-7
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 5 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.